Royalty Pharma plc

RPD.F·Frankfurt·Healthcare
Compare
59.76+2.05 (+3.55%)today
As of Nov 5, 8:48 AM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close57.71
Open59.76
Day range—
52-week range31.6559.76
Off day high0.00%
Off 52-week high0.00%
Volume150
Avg. volume (3M)28.00
Market cap34.53B
EPS (TTM)1.34
Forward P/E19.66
P/E ratio (TTM)44.60
Dividend yield1.45% (0.8400)
Beta (5Y)0.36
Shares outstanding445.28M
Short interest—
Earnings dateNov 4, 2026
Analyst target—
Profit margin32.02%

Against its peers

Compare in full ›
RPD.F ROIV 3759.HK REGN 0NZU.IL LGND
Market cap 34.53B 27.61B 55.85B 96.28B 14.34B 6.32B
P/E (TTM) 44.6 — 27.4 20.6 — 127.0
Forward P/E 19.7 -27.5 17.2 13.2 — 25.9
Price/book 4.4 6.5 2.8 2.8 8.1 6.6
Dividend yield 1.45% — 0.78% 0.40% — —
1-year change +70.43% +78.15% +19.72% +51.10% −50.69% +64.68%
Today +3.55% +6.08% +3.47% −4.39% +0.90% +0.83%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Royalty Pharma's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Roivant Sciences Ltd.ROIV · Biotechnology 27.61B 38.23 +6.08%
Pharmaron Beijing Co., Ltd.3759.HK · Biotechnology 55.85B 30.400 +3.47%
Regeneron Pharmaceuticals, Inc.REGN · Biotechnology 96.28B 930.67 −4.39%
Zealand Pharma A/S0NZU.IL · Biotechnology 14.34B 240.50 +0.90%
Ligand Pharmaceuticals IncorporatedLGND · Biotechnology 6.32B 316.13 +0.83%
Bio-Thera Solutions, Ltd.688177.SS · Biotechnology 7.38B 17.82 +2.95%
Shanghai Junshi Biosciences Co., Ltd.8SJ.F · Biotechnology 1.84B 1.7900 +1.70%
Fortrea Holdings Inc.FTRE · Biotechnology 2.01B 20.83 −0.57%

Also based in New York, New York, then elsewhere in New York.

Company Mkt cap Price Today
Citigroup Inc.C · New York, NYOdds 206.47B 124.74 +1.65%
Coinbase Global, Inc.COIN.BA · New York, NY 67.45T 9,435.00 +4.43%
The Bank of New York Mellon CorporationBNY.BA · New York, NY 43.07T 128,000.00 +2.58%
Verizon Communications Inc.VZ · New York, NYOdds 191.36B 46.17 +2.06%
Pfizer Inc.PFE · New York, NYOdds 175.50B 30.79 +2.63%
JPMorgan Chase & Co.JPM · New York, NYOdds 935.06B 352.11 +4.18%
Colgate-Palmolive CompanyCL.BA · New York, NY 14.28T 53,900.00 +1.60%
Morgan StanleyMS · New York, NYOdds 303.56B 193.97 +4.23%

The stocks whose daily moves over the past year went most closely with Royalty Pharma's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Royalty Pharma plcRPD.MU · Correlation 0.54 34.42B 59.57 0.00%

What visitors to Royalty Pharma's page also look at.

Company Mkt cap Price Today
Bio-Techne Corp.TE1.F 9.93B 63.22 −0.97%
ROYALTY PHARMA PLCRPD.MU 34.42B 59.57 0.00%
Alnylam Pharmaceuticals IncDUL.F 19.44B 145.15 +0.07%
Halozyme Therapeutics Inc.RV7.F 13.05B 115.00 +1.23%
NEUROCRINE BIOSCIENCES INC.NB3.F 14.69B 145.15 +0.10%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All RPD.F news ›
The Globe and Mail·Positive

Royalty Pharma (RPRX) Gets a Buy from Citi

In a report released today, Geoff Meacham from Citi maintained a Buy rating on Royalty Pharma, with a price target of $70.00. Meacham covers the Healthcare sector, focusing on stocks such as Amgen, Regeneron, and Biogen. According to…

RPRXREGNRXRX
The Motley Fool·

Should You Buy Royalty Pharma Stock Before Nov. 4?

Royalty Pharma (RPRX -0.70%) will report Q3 2026 earnings pre-market on Nov. 4. After pulling back in September due to a major setback with one of its drug candidates, the pharmaceutical royalty holding company's shares have been soaring…

LLYJNJMRKPFE

From the 4Search news index, newest first.

In the news

29mentions in 30 days
29with it in the headline
Positivesentiment

Mentioned with

Novartis13Pfizer12Non-Gaap10Johnson & Johnson9Novo Nordisk9Royalty Pharma Plc9Eli Lilly8Merck & Co., Inc.8

People in the coverage

Thomas Niel20Prevymis18Danessa Lincoln13Abbvie11Sarita Garza9Tristan Rich9

Themes

Healthcare13Rprx12Pharmaceuticals11Equities8Comparison7Dividend7Dividends7Biotechnology6

Most coverage from

  1. marketscreener.com9
  2. marketbeat.com4
  3. themarketsdaily.com4
  4. fool.com3
  5. stocktitan.net3

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 25 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance